YOLOAdvisorShares Pure Cannabis ETF

Grow my money7y track recordRanked #1,283 of 2,960 in this goal

Seeks long-term capital appreciation.

By AdvisorShares · Launched 2019

Annual Cost

0.51%

#2,701 of 5,562 · average

Fund Size

$36M

#3,863 of 5,562 · small

Return (1Y)Goal

+52.0%

Track Record

7 years

#1,898 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$15,580+55.8%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Active selection

Focus

Biotech & Genomics

What it actually holds

By weight

Concentration

Top 10 holdings = 95.5% of fundconcentrated

AdvisorShares Pure US Cannabis ETF

46.0%

Village Farms International In

18.9%

High Tide Inc

9.1%

SNDL Inc

4.4%

Organigram Global Inc

4.1%

DREY INST PREF GOV MM-MDSVXX

3.6%

Cronos Group Inc

3.6%

Charlottes Web Holdings Inc

2.0%

Aurora Cannabis Inc

1.9%

Jazz Pharmaceuticals PLC

1.8%

Asset allocation

Stocks

51.5%

Cash

44.7%

Other

2.5%

Bonds

1.3%

By sector

Healthcare

67.3%

Consumer Defensive

32.7%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

74.9%High

Year-on-year price swings

Max drawdown

-94.7%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.27Below average

Sortino (3Y)

0.45Moderate downside risk

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks long-term capital appreciation.
Strategy: Actively invests primarily in equity securities of companies deriving significant revenue from marijuana and hemp. Focuses on mid- and small-cap companies, utilizing derivatives and total return swaps for exposure. Concentrates at least 25% in pharmaceuticals and biotechnology within healthcare.
Inception date: April 17, 2019
Fund family: AdvisorShares